문의하기 아이콘
문의하기 텍스트
top 아이콘

CORE LOG

Empowering medical imaging with Coreline AI technology.
Check out our innovative resources.

How AI is Transforming Chest CT Reading: Insights from ATS 2025
Insight

How AI is Transforming Chest CT Reading: Insights from ATS 2025

AI is rapidly reshaping chest CT interpretation in clinical practice. At ATS 2025, leading sessions will highlight real-world applications of AI in pulmonary imaging. Coreline Soft will showcase its 3-in-1 solution for lung cancer, CAD, and COPD—bridging innovation with impact.

#Coreline Soft

#ATS 2025

#AI Chest CT

#Lung cancer screening

#LDCT

#Radiology AI
Coreline Soft
Coreline Soft
2025. 04. 21
new 아이콘
The Impact of the USPSTF Lawsuit on the Future of Preventive Healthcare

Insight

The Impact of the USPSTF Lawsuit on the Future of Preventive Healthcare

#Preventive healthcare

#USPSTF lawsuit

#Kennedy v. Braidwood Management

#ACA preventive services

#Lung cancer screening

#Low-dose CT (LDCT)

#AI-driven preventive care
Coreline Soft
Coreline Soft
2025. 04. 28
new 아이콘
Why Now Is the Right Time to Enter the AI Medical Device Market

Insight

Why Now Is the Right Time to Enter the AI Medical Device Market

#Coreline Soft

#Medical AI

#AI medical device approval

#digital health law

#Korea regulation AI
Coreline Soft
Coreline Soft
2025. 04. 17
new 아이콘
Why We Must Go Beyond the

Insight

Why We Must Go Beyond the "High-Risk Group" in Lung Cancer Screening

#Coreline Soft

#Lung Cancer Screening

#LDCT lung cancer screening

#lung cancer risk stratification

#Medical AI
Dr. Ryoungwoo Jang, Clinical Research Lead
Dr. Ryoungwoo Jang, Clinical Research Lead
2025. 04. 14
CATEGORY
All
Insight

The Impact of the USPSTF Lawsuit on the Future of Preventive Healthcare

The Impact of the USPSTF Lawsuit on the Future of Preventive Healthcare

The Kennedy v. Braidwood lawsuit challenges the ACA’s preventive service mandate, potentially ending free access to essential screenings like colonoscopies, HIV prevention, and lung cancer CT scans. This shift signals a major transition toward precision-driven, value-based preventive care models.

#Preventive healthcare

#USPSTF lawsuit

#Kennedy v. Braidwood Management

#ACA preventive services

#Lung cancer screening

#Low-dose CT (LDCT)

#AI-driven preventive care
Coreline Soft
Coreline Soft
2025. 04. 28
The Impact of the USPSTF Lawsuit on the Future of Preventive Healthcare
Insight

How AI is Transforming Chest CT Reading: Insights from ATS 2025

How AI is Transforming Chest CT Reading: Insights from ATS 2025

AI is rapidly reshaping chest CT interpretation in clinical practice. At ATS 2025, leading sessions will highlight real-world applications of AI in pulmonary imaging. Coreline Soft will showcase its 3-in-1 solution for lung cancer, CAD, and COPD—bridging innovation with impact.

#Coreline Soft

#ATS 2025

#AI Chest CT

#Lung cancer screening

#LDCT

#Radiology AI
Coreline Soft
Coreline Soft
2025. 04. 21
How AI is Transforming Chest CT Reading: Insights from ATS 2025
Insight

Why Now Is the Right Time to Enter the AI Medical Device Market

Why Now Is the Right Time to Enter the AI Medical Device Market

Success in the AI medical device market depends on more than innovation—it hinges on mastering regulation and reimbursement. With Korea’s first-in-the-world Digital Health Product Act and global LDCT screening programs taking shape, this is a pivotal moment for AI-powered diagnostics. Learn how Coreline Soft is leading with regulatory strategy and clinical readiness to transform early detection into global opportunity.

#Coreline Soft

#Medical AI

#AI medical device approval

#digital health law

#Korea regulation AI
Coreline Soft
Coreline Soft
2025. 04. 17
Why Now Is the Right Time to Enter the AI Medical Device Market
Insight

Why We Must Go Beyond the "High-Risk Group" in Lung Cancer Screening

Why We Must Go Beyond the

Today’s lung cancer screening model defines high-risk by age and smoking history—but not all smokers carry the same risk. It's time to move toward a stratified screening model based on individual risk profiles. Discover how precision medicine and AI-driven follow-up can reshape the future of lung cancer care.

#Coreline Soft

#Lung Cancer Screening

#LDCT lung cancer screening

#lung cancer risk stratification

#Medical AI
Dr. Ryoungwoo Jang, Clinical Research Lead
Dr. Ryoungwoo Jang, Clinical Research Lead
2025. 04. 14
Why We Must Go Beyond the
Insight

Australia’s Lung Cancer Screening Shift: Highlights from ALCC 2025

Australia’s Lung Cancer Screening Shift: Highlights from ALCC 2025

ALCC 2025 is an important event that brings together leading experts in the field of lung cancer screening in Australia to share the latest research findings and technologies. CorelineSoft participated in the event to discuss innovative approaches to early diagnosis and treatment of lung cancer, new screening technologies, and the future direction of lung cancer screening policy in Australia.

#ALCC2025

#AustraliaHealthcare

#LungCancerScreening

#MedicalAI

#Corelinesoft
Overseas Business Unit, Jo Hyang Lee
Overseas Business Unit, Jo Hyang Lee
2025. 03. 27
Australia’s Lung Cancer Screening Shift: Highlights from ALCC 2025
Insight

The Future of Lung Cancer Screening Programs: Evolving with AI

The Future of Lung Cancer Screening Programs: Evolving with AI

With the implementation of the National Lung Cancer Screening Program, the effectiveness of LDCT screening in reducing lung cancer mortality has been confirmed. But how will AI technology impact LDCT screening in the future?

#National Lung Cancer Screening Program

#Lung Cancer Screening

#LDCT Screening

#Corelinesoft
Corelinesoft
Corelinesoft
2025. 03. 20
The Future of Lung Cancer Screening Programs: Evolving with AI
Insight

Strategy to enter the global medical AI market through overseas clinical trials

Strategy to enter the global medical AI market through overseas clinical trials

Coreline Soft is strengthening its global competitiveness in AI-powered medical devices through FDA certification and international clinical research. Let’s explore the objectives behind its participation in the Innovative Medical Device Program and multinational collaborations.

#CorelineSoft

#MedicalAI

#ClinicalTrials
Research Asset Team, Seungjun Na
Research Asset Team, Seungjun Na
2025. 03. 17
Strategy to enter the global medical AI market through overseas clinical trials
Insight

U.S. Healthcare AI Market in 2025: Growth Drivers & Clinical Impact

U.S. Healthcare AI Market in 2025: Growth Drivers & Clinical Impact

Explore key trends and innovations shaping the U.S. healthcare AI market in 2025. See how AI is transforming the industry.

#HealthcareAI

#HealthTech

#AITrends

#DigitalHealth
Corelinesoft
Corelinesoft
2025. 03. 14
U.S. Healthcare AI Market in 2025: Growth Drivers & Clinical Impact
  • 1
  • 2
  • 3
  • 4

Contact

Please leave your inquiry if you have any questions regarding our products, recruitment, investment, or any other matters.

Contact us